Treatment of vaginal candidiasis in pregnancy with a single clotrimazole 500 mg vaginal pessary

dc.contributor.authorLindeque, B. G.en_ZA
dc.contributor.authorVan Niekerk, W. A.en_ZA
dc.date.accessioned2011-03-18T14:57:38Z
dc.date.available2011-03-18T14:57:38Z
dc.date.issued1984
dc.descriptionCITATION: Lindeque, B. G. & Van Niekerk, W. A. 1984. South African Medical Journal, 65:123-124.
dc.descriptionThe original publication is available at http://www.samj.org.za
dc.description.abstractA single vaginal pessary containing clotrimazole 500 mg (Canesten; Bayer-Miles) was used to treat candidiasis during a prospective, mycologically controlled trial among 46 patients in the second and third trimesters of pregnancy. Positive cultures were obtained from vaginal swabs before commencement of treatment. Swabs were taken 1 week and 1 month after treatment. Four patients were lost to follow-up. One week after treatment 83.3% of the patients were cured on microscopic and mycological examination, and all of the patients had relief of symptoms. The recurrence rate was 5.7% after 1 month. Of the 7 patients in whom treatment was unsuccessful, 3 were available for repeat treatment and all 3 responded successfully to a second course.
dc.description.versionPublisher’s version
dc.identifier.issn2078-5135 (online)
dc.identifier.issn0256-9574 (print)
dc.identifier.urihttp://hdl.handle.net/10019.1/7552
dc.language.isoen
dc.publisherHealth & Medical Publishing Group
dc.rights.holderSouth African Medical Journal
dc.subjectCandidiasisen_ZA
dc.titleTreatment of vaginal candidiasis in pregnancy with a single clotrimazole 500 mg vaginal pessaryen_ZA
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
lindeque_treatment_1984.pdf
Size:
1.47 MB
Format:
Adobe Portable Document Format
Description:
Download article